Showing results (101-110 of 134) with videos related to
Sort By:
Pageof 14
Kidney International|February 22, 2023
Identification of proteinase 3 autoreactive CD4<sup>+</sup>T cells and their T-cell receptor repertoires in antineutrophil cytoplasmic antibody-associated vasculitisRavi Kumar Sharma, Niyaz Yoosuf, Marcelo Afonso, et al.Journal of the American Society of Nephrology : JASN|March 9, 2022
Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies <i>in vivo</i> in Severe Kidney Disease: An Open-Label Phase 2a StudyFredrik Uhlin, Wladimir Szpirt, Andreas Kronbichler, et al.Lancet (London, England)|October 13, 2015
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 studyDavid Roth, David R Nelson, Annette Bruchfeld, et al.Clinical Kidney Journal|May 25, 2026
The evolving field of nephrology: what comes next? A report from the European Renal Association Scientific Advisory BoardMehmet Kanbay, Sidar Copur, Giovambattista Capasso, et al.Kidney International|November 21, 2022
Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney DiseasePaul Martin, Ahmed A Awan, Marina C Berenguer, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 10, 2023
Management of antineutrophil cytoplasmic antibody-associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendationsMarta Casal Moura, Philipp Gauckler, Hans-Joachim Anders, et al.African Journal of Nephrology : Official Publication of the African Association of Nephrology. African Association of Nephrology|December 23, 2020
Hepatitis C virus infection and global kidney health: the consensus proceedings of the International Federation of Kidney FoundationsGamal Saadi, Kamyar Kalantar-Zadeh, Piero Almasio, et al.Kidney Medicine|January 3, 2023
Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical TrialObbo W Bredewold, Joe Chan, My Svensson, et al.Annals of Internal Medicine|December 11, 2023
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice GuidelineAhmed Arslan Yousuf Awan, Marina C Berenguer, Annette Bruchfeld, et al.Frontiers in Immunology|September 28, 2023
COVID-19 outcomes in patients with a history of immune-mediated glomerular diseasesPhilipp Gauckler, Jana S Kesenheimer, Duvuru Geetha, et al.Pageof 14